NO20060184L - Fremgangsmate for fremstilling av ikke-peptid substituerte spirobenzoazepinderivater - Google Patents

Fremgangsmate for fremstilling av ikke-peptid substituerte spirobenzoazepinderivater

Info

Publication number
NO20060184L
NO20060184L NO20060184A NO20060184A NO20060184L NO 20060184 L NO20060184 L NO 20060184L NO 20060184 A NO20060184 A NO 20060184A NO 20060184 A NO20060184 A NO 20060184A NO 20060184 L NO20060184 L NO 20060184L
Authority
NO
Norway
Prior art keywords
preparation
derivatives
peptide substituted
peptide
substituted spirobenzoazepine
Prior art date
Application number
NO20060184A
Other languages
English (en)
Inventor
Frank J Villani
Xiaohu Deng
Birdella Kenney
Jimmy T Liang
Neelakandha Mani
Fan Zhang-Plasket
Hua Zhong
Original Assignee
Janssen Pharmaceutica Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Janssen Pharmaceutica Nv filed Critical Janssen Pharmaceutica Nv
Publication of NO20060184L publication Critical patent/NO20060184L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C233/00—Carboxylic acid amides
    • C07C233/64—Carboxylic acid amides having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings
    • C07C233/81—Carboxylic acid amides having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by carboxyl groups
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/10—Antioedematous agents; Diuretics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/14—Vasoprotectives; Antihaemorrhoidals; Drugs for varicose therapy; Capillary stabilisers
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D223/00—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom
    • C07D223/14—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
    • C07D223/32—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom condensed with carbocyclic rings or ring systems containing carbocyclic rings other than six-membered

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Neurosurgery (AREA)
  • Diabetes (AREA)
  • Vascular Medicine (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Reproductive Health (AREA)
  • Psychiatry (AREA)
  • Endocrinology (AREA)
  • Hospice & Palliative Care (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Epoxy Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)

Abstract

Det beskrives nye spirobenzoazepinforbindelser, nye prosesser for fremstilling av ikke-peptidsubstituert spirobenzodiazepinderivater og nye prosesser for fremstilling av mellomprodukter for fremstilling av slike derivater. Videre beskrives det mellomprodukter for fremstilling av ikke-peptidsubstituerte spirobenzoazepinderivater.
NO20060184A 2003-06-17 2006-01-11 Fremgangsmate for fremstilling av ikke-peptid substituerte spirobenzoazepinderivater NO20060184L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US47951503P 2003-06-17 2003-06-17
PCT/US2004/019951 WO2005000819A1 (en) 2003-06-17 2004-06-16 Process for the preparation of nonpeptide substituted spirobenzoazepine derivatives

Publications (1)

Publication Number Publication Date
NO20060184L true NO20060184L (no) 2006-03-13

Family

ID=33551892

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20060184A NO20060184L (no) 2003-06-17 2006-01-11 Fremgangsmate for fremstilling av ikke-peptid substituerte spirobenzoazepinderivater

Country Status (20)

Country Link
US (2) US20040259857A1 (no)
EP (1) EP1633721A1 (no)
JP (1) JP2007516177A (no)
KR (1) KR20060023164A (no)
CN (1) CN1835926A (no)
AR (1) AR044781A1 (no)
AU (1) AU2004252135A1 (no)
BR (1) BRPI0411652A (no)
CA (1) CA2529513A1 (no)
CL (1) CL2004001508A1 (no)
CO (1) CO5650238A2 (no)
CR (1) CR8167A (no)
EA (1) EA200501829A1 (no)
HR (1) HRP20051005A2 (no)
IL (1) IL172629A0 (no)
IS (1) IS8185A (no)
NO (1) NO20060184L (no)
RS (1) RS20050933A (no)
TW (1) TW200510323A (no)
WO (1) WO2005000819A1 (no)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AR044782A1 (es) 2003-06-17 2005-10-05 Ortho Pharma Corp Espirobenzazepinas sustituidas utiles como antagonistas de los receptores de vasopresina
CA2637838A1 (en) * 2006-01-20 2007-07-26 Janssen Pharmaceutica N.V. Novel solid forms of (4r)-1-¬4-(2-chloro-5-fluorobenzoyl)amino-3-methoxybenzoyl|-1,2,3,5-tetrahydro-spiro¬4h-1-benzazepine-4,1'-¬2|cyclopentene|-3'-carboxylic acid
EP2078022B1 (en) * 2006-09-22 2011-11-09 Janssen Pharmaceutica N.V. Spiro benzazepines used as vasopressin antagonists
US7825111B2 (en) 2006-09-22 2010-11-02 Janssen Pharmaceutica Nv Substituted spiroheterocycles
AR066834A1 (es) * 2007-06-06 2009-09-16 Janssen Pharmaceutica Nv Espirobenzoazepanos como antagonistas de vasopresina, composiciones farmaceuticas que los contienen, proceso de preparacion y usos para el tratamiento de afecciones cardiacas, renales y del sistema nervioso central.
JP2009035513A (ja) * 2007-08-02 2009-02-19 Ube Ind Ltd ４−ｎ−（メチルベンゾイル）アミノ−２−メチル安息香酸の製法
CN105609662B (zh) * 2015-12-22 2017-12-12 洪杰波 一种钙钛矿光伏材料专用的空穴传输材料的制备方法
JP2023537274A (ja) * 2020-08-07 2023-08-31 カスマ セラピューティクス， インコーポレイテッド Ｔｒｐｍｌモジュレーター
CN112939864B (zh) * 2021-01-29 2022-05-06 中国医科大学 螺[苯并[c]氮杂-1,1’-环己基]-3-酮类化合物
CN113735792B (zh) * 2021-09-22 2024-10-18 上海新礼泰药业有限公司 氯苯唑酸葡胺及其中间体的制备方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW462964B (en) * 1998-05-26 2001-11-11 Sumitomo Pharma Guanidine derivatives for the treatment and prevention of disorders caused by inhibiting hyperactivity of Na/H exchange transport system and process for producing the same
ATE305454T1 (de) * 2000-07-05 2005-10-15 Ortho Mcneil Pharm Inc Nichtpeptidische substituierte spirobenzoazepine als vasopressin antagonisten
AR044782A1 (es) * 2003-06-17 2005-10-05 Ortho Pharma Corp Espirobenzazepinas sustituidas utiles como antagonistas de los receptores de vasopresina

Also Published As

Publication number Publication date
CN1835926A (zh) 2006-09-20
IL172629A0 (en) 2006-04-10
HRP20051005A2 (en) 2006-09-30
EA200501829A1 (ru) 2006-06-30
BRPI0411652A (pt) 2006-08-08
US20040259857A1 (en) 2004-12-23
US20090105220A1 (en) 2009-04-23
EP1633721A1 (en) 2006-03-15
CR8167A (es) 2008-09-10
TW200510323A (en) 2005-03-16
IS8185A (is) 2005-12-15
CA2529513A1 (en) 2005-01-06
AU2004252135A1 (en) 2005-01-06
RS20050933A (en) 2008-04-04
WO2005000819A1 (en) 2005-01-06
CO5650238A2 (es) 2006-06-30
KR20060023164A (ko) 2006-03-13
AR044781A1 (es) 2005-10-05
CL2004001508A1 (es) 2005-05-27
JP2007516177A (ja) 2007-06-21

Similar Documents

Publication Publication Date Title
NO20060184L (no) Fremgangsmate for fremstilling av ikke-peptid substituerte spirobenzoazepinderivater
NO20082266L (no) Nye 1-azabicykloalkylderivater for behandling av psykotiske og neurodegenerative forstyrrelser
NO20093060L (no) Spirosykliske sykloheksanderivater
NO20082305L (no) Mikrobiologisk stabilisert ol
NO20054762L (no) Polymorphs of aripiprazole
EA200501928A1 (ru) Пирролодигидроизохинолины как ингибиторы pde10
NO20061396L (no) Nye heterocykliske forbindelser som HSP90-inhibitorer
NO20053395L (no) Framgangsmate for styring av prosess i borehull, bruk av seismisk kommunikasjon.
ATE495162T1 (de) Azabicyclo-octan und nonan derivate mit ddp-iv hemmender wirkung
NO20091976L (no) Nye forbindelser
IL172357A0 (en) Method for the production of substituted 3-aryl-butyl amine compounds
NO20056130L (no) Nye substituerte 3-svovelindoler
TNSN07196A1 (en) Potentiators of glutamate receptors
TW200604184A (en) Processes and intermediates useful for preparing fused heterocyclic kinase inhibitors
NO20074037L (no) Farmasoytiske formuleringer med vedvarende frigivelse
BRPI0414599A (pt) pirrol-indóis substituìdos
NO20066078L (no) Metode for fremstilling av Entecavir og nye mellomprodukter derav via karbon-silisium oksidasjon
NO20071254L (no) Fremgangsmate for fremstilling av irbesartan og mellomprodukter derav.
DE602004013405D1 (de) Polymorphe formen von valsartan
NO20072473L (no) Fremgangsmate for fremstilling av kinolinforbindelser og oppnadde produkter
DK1456212T3 (da) 6-aminomorphinanderivater, fremgangsmåder til fremstilling heraf og disses anvendelse
NO20043842L (no) Nye krystallformer av atorvastatinhemikalsium og fremgangsmater for fremstilling derav, savel som nye fremgangsmater for fremstilling av atorvastatinhemikalsiumform I, VIII og IX
PT1528923E (pt) Derivados de n-((3-oxo-2,3-di-hidro-1h-isoindol-1-il)acetil)guanidina como inibidores de nhe-1 para o tratamento de enfarte e angina de peito
NO20063611L (no) Fremgangsmater for fremstilling av aryl- og heteroarylsulfonylhalider
NO20081617L (no) Metoder for fremstilling av Glutaminsyrederivater

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application